Page last updated: 2024-12-06

mesudipine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Mesudipine is a dihydropyridine calcium channel blocker with potential therapeutic applications in the treatment of cardiovascular diseases. It exhibits potent vasodilatory effects, leading to a decrease in blood pressure and improved blood flow. Research indicates that mesudipine selectively inhibits calcium influx through L-type calcium channels, primarily found in vascular smooth muscle cells, resulting in smooth muscle relaxation and vasodilation. Studies have explored its efficacy in managing hypertension, angina pectoris, and other cardiovascular disorders. Mesudipine's importance lies in its potential to provide alternative treatment options for these conditions, particularly for patients who may not respond well to existing therapies. The compound is being studied to further understand its pharmacological profile, optimize its therapeutic efficacy, and explore potential new applications in cardiovascular medicine.'

mesudipine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68817
CHEMBL ID2106863
SCHEMBL ID1900480
MeSH IDM0111456

Synonyms (17)

Synonym
mesudipine
62658-88-2
diethyl 2,6-dimethyl-4-(2-methylsulfanylpyridin-3-yl)-1,4-dihydropyridine-3,5-dicarboxylate
SCHEMBL1900480
CHEMBL2106863
mesudipinum [inn-latin]
einecs 263-677-3
mesudipinum
mesudipino [inn-spanish]
dt27w93dff ,
mesudipino
unii-dt27w93dff
diethyl 1',4'-dihydro-2',6'-dimethyl-2-(methylthio)(3,4'-bipyridine)-3',5'-dicarboxylate
mesudipine [inn]
diethyl 2',6'-dimethyl-2-(methylsulfanyl)-1',4'-dihydro[3,4'-bipyridine]-3',5'-dicarboxylate
DTXSID00978230
Q27276586
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.36 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]